Comparison of pegfilgrastim and daily G-CSF for CD34+ cell mobilization in healthy donors and post-transplant engraftment: The Pegfilgrastim-23 Study

Transplantation and Cellular Therapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles